NBY missed EPS expectations by 7.11%
Nov 07, 2024, 11:35 PM
0.00%
What does NBY do
NovaBay Pharmaceuticals, based in Emeryville, California, specializes in eyecare and wound care products, including the Avenova line and hypochlorous acid solutions for various medical applications. The company went public on October 26, 2007, and employs 24 staff members.
Novabay Pharmaceuticals (NBY) reported a negative EPS surprise in its most recent quarterly earnings. For the most recent quarter, Novabay Pharmaceuticals's actual EPS was -$0.33, missing the estimate of -$0.31 per share, resulting in a -7.11% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.